Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 364 across all filing types
Latest filing 2025-05-06 Share Issue/Capital Cha…
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Exercise of Options and Cleansing Statement 1 page
Share Issue/Capital Change Classification · 100% confidence The document is a notice about the exercise of options and the issuance of new shares by Singular Health Group Limited. It includes details about the number of shares issued, the exercise prices, and references to compliance with the Corporations Act 2001. It also mentions an Appendix 2A for quotation of shares. The document is short (2345 characters) and primarily serves as an announcement of a capital change event rather than a detailed financial report or regulatory filing. There is no financial statement or detailed analysis present. Therefore, this document fits best under the category of Share Issue/Capital Change (SHA).
2025-05-06 English
Appendix 3Y - Change of Director's Interest Notice x 3 7 pages 21.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director's Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by company directors, including allotments of unlisted options and shares as part of remuneration packages. The document is a formal notification of personal share transactions by company directors. It does not contain financial statements, earnings data, or management discussion, but rather reports insider transactions. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length and content confirm it is not a brief announcement or a certification but a detailed insider transaction report.
2025-04-21 English
Application for quotation of securities - SHG 8 pages 20.6KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) form used for the application for quotation of securities. It details the issuance and quotation of new securities resulting from options being exercised or convertible securities being converted. The document includes specifics such as the number of securities, issue date, issue price, and the total issued capital following the quotation. This type of document is not a financial report, earnings release, or management discussion but rather a formal announcement related to capital changes and securities quotation on the exchange. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not merely an announcement of a report but a detailed filing about securities issuance and quotation.
2025-04-16 English
Exercise of Options and Cleansing Statement 1 page
Capital/Financing Update Classification · 95% confidence The document is a notice about the exercise of options and the issuance of new shares by Singular Health Group Limited. It includes a cleansing notice pursuant to Section 708A(5)(e) of the Corporations Act 2001, which is a regulatory compliance statement related to the issuance of shares without disclosure under the Corporations Act. The document does not contain financial statements, detailed financial analysis, or management discussion. It is an announcement about a capital raising event through the exercise of options and the related regulatory notice. The presence of an Appendix 2A for quotation of shares further supports this being a capital/financing update. The document length is short (2272 characters), and it is not a report or a certification but a regulatory announcement about capital changes. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-04-16 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 431.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Activities Report for the Quarter Ended 31 March 2025' and contains detailed operational highlights, strategic collaborations, product development milestones, investor relations activities, and a comprehensive Appendix 4C quarterly cash flow report as required by ASX Listing Rule 4.7B. The report includes actual financial data such as cash flows from operating, investing, and financing activities, expenditure breakdowns, and cash balances. It is a comprehensive quarterly report covering the company's activities and financial performance for the quarter, not merely an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2025
2025-04-15 English
Notification regarding unquoted securities - SHG 11 pages 31.5KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted options and securities by Singular Health Group Ltd. It includes specifics about the number of securities issued, their terms, and the context of issuance such as being part of remuneration or incentive packages. The document references previous announcements (Appendix 3B) and shareholder approvals but does not contain financial statements or earnings data. It is a formal notification of securities issuance to the market, consistent with announcements related to capital changes or share issues. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive notification of capital changes.
2025-04-14 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.